Bandingkan Harga & Kinerja Sinergi Inti Andalan Prima Tbk. (INET) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Sinergi Inti Andalan Prima Tbk. dan Organon Pharma Indonesia Tbk.: Sinergi Inti Andalan Prima Tbk. diperdagangkan di Rp344 (kapitalisasi pasar 7,74 T, volume 24 jam 668,43 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Sinergi Inti Andalan Prima Tbk. jauh lebih besar — sekitar 74,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INET | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 7,74 T | 104,4 M |
Volume | 668,43 jt | — |
Lot | 6,68 jt | — |
Perputaran | 223,38 M | — |
Harga Rata-rata | 334,19 | — |
Nilai Transaksi | 223,38 M | — |
Harga Ekuilibrium Indikatif | 344 | — |
Volume Ekuilibrium Indikatif | 105,54 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Sinergi Inti Andalan Prima Tbk.
PT Sinergi Inti Andalan Prima Tbk (the Company) was established on December 16, 2016 based on Notarial Deed No. 1 of Devi Prihartanti, S.H., notary in South Tangerang. The Company started its commercial operations in 2017.
Selengkapnya di halaman INET →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
